Published in Ann Rheum Dis on December 01, 1999
Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum (2010) 3.84
Epidemiology and genetics of rheumatoid arthritis. Arthritis Res (2002) 3.37
Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment. Ann Rheum Dis (2006) 1.44
The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study. Arthritis Res Ther (2014) 1.42
Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis (2005) 1.18
Rheumatoid arthritis prevalence, incidence, and mortality rates: a nationwide population study in Taiwan. Rheumatol Int (2012) 1.02
Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol (2010) 1.00
Prevalence and incidence of rheumatoid arthritis in South Korea. Rheumatol Int (2012) 1.00
Existing data sources for clinical epidemiology: The Danish Knee Arthroplasty Register. Clin Epidemiol (2012) 0.97
Incidence of Rheumatoid Arthritis in the Southern part of Denmark from 1995 to 2001. Open Rheumatol J (2007) 0.93
Is rheumatoid arthritis disappearing? Ann Rheum Dis (2004) 0.80
Should infection still be considered as the most likely triggering factor for rheumatoid arthritis? Ann Rheum Dis (2004) 0.79
Altered pattern of lipids in plasma and erythrocyte membranes of rheumatoid arthritis patients. Indian J Clin Biochem (2005) 0.78
Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate. Adv Ther (2016) 0.77
Prevalence of rheumatoid arthritis in Serbia. Rheumatol Int (2013) 0.77
Prevalence of rheumatoid arthritis in the southern part of denmark. Open Rheumatol J (2011) 0.77
Health status in rheumatoid arthritis over 7 years. Ann Rheum Dis (2005) 0.77
Prevalence and incidence of rheumatoid arthritis in Italy. Rheumatol Int (2014) 0.77
Lipid peroxidation and antioxidant status in patients with rheumatoid arthritis. Indian J Clin Biochem (2008) 0.75
Replication of british rheumatoid arthritis susceptibility Loci in two unrelated chinese population groups. Clin Dev Immunol (2013) 0.75
Clinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab. J Orthop Sci (2015) 0.75
Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy. Clinicoecon Outcomes Res (2016) 0.75
Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate. Clinicoecon Outcomes Res (2017) 0.75
Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. Clin Rheumatol (2016) 0.75
The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol (1994) 3.82
The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19
Rheumatoid arthritis, the contraceptive pill, and androgens. Ann Rheum Dis (1993) 1.33
Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987-1989. Arthritis Rheum (1991) 1.30
Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin Arthritis Rheum (1997) 1.25
Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period. Arthritis Rheum (1994) 1.24
Epidemiology of rheumatoid arthritis in Finland. Semin Arthritis Rheum (1998) 1.20
Incidence of rheumatoid arthritis in central Massachusetts. Arthritis Rheum (1993) 1.14
Changes in the incidence and prevalence of rheumatoid arthritis in England and Wales, 1970-1982. Semin Arthritis Rheum (1990) 1.13
Incidence of rheumatoid arthritis in Finland during 1980-1990. Ann Rheum Dis (1996) 1.10
A reappraisal of the measurement of disease occurrence in rheumatoid arthritis. J Rheumatol (1992) 0.99
A longitudinal population survey of rheumatoid arthritis in a rural district in Wakayama. Ryumachi (1981) 0.96
Rheumatoid arthritis and gout in Hiroshima and Nagasaki, Japan. A prevalence and incidence study. J Chronic Dis (1971) 0.94
Age, sex, and the familial risk of rheumatoid arthritis. Am J Epidemiol (1996) 0.88
Rheumatoid arthritis in Hiroshima and Nagasaki, Japan. Prevalence, incidence, and clinical characteristics. Arthritis Rheum (1967) 0.86
Increased rate of hysterectomy in women undergoing surgery for osteoarthritis of the knee. Osteoarthritis Cartilage (1995) 0.81
[Ankylosing spondylitis]. Ryumachi (1976) 0.80
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol (1980) 113.75
Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry Clin Neurosci (2001) 36.50
Evolutionary rate at the molecular level. Nature (1968) 33.15
The number of heterozygous nucleotide sites maintained in a finite population due to steady flux of mutations. Genetics (1969) 22.59
A model of mutation appropriate to estimate the number of electrophoretically detectable alleles in a finite population. Genet Res (1973) 13.08
Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature (1996) 10.67
A stochastic model concerning the maintenance of genetic variability in quantitative characters. Proc Natl Acad Sci U S A (1965) 9.20
Obesity, cigarette smoking, and telomere length in women. Lancet (2005) 8.59
Artemisinins target the SERCA of Plasmodium falciparum. Nature (2003) 7.72
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66
The substitutional load in a finite population. Heredity (Edinb) (1969) 7.56
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature (1998) 7.38
Linkage disequilibrium at steady state determined by random genetic drift and recurrent mutation. Genetics (1969) 7.33
The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell (2006) 6.80
Protein polymorphism as a phase of molecular evolution. Nature (1971) 6.68
Theoretical foundation of population genetics at the molecular level. Theor Popul Biol (1971) 6.38
The probability of consanguineous marriages. Genetics (1966) 5.85
Estimation of evolutionary distances between homologous nucleotide sequences. Proc Natl Acad Sci U S A (1981) 5.34
On the stochastic model for estimation of mutational distance between homologous proteins. J Mol Evol (1972) 5.16
Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med (1986) 4.99
On some principles governing molecular evolution. Proc Natl Acad Sci U S A (1974) 4.97
Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (1986) 4.97
Multilayer white light-emitting organic electroluminescent device. Science (1995) 4.86
Genetic variability maintained in a finite population due to mutational production of neutral and nearly neutral isoalleles. Genet Res (1968) 4.83
The rate of molecular evolution considered from the standpoint of population genetics. Proc Natl Acad Sci U S A (1969) 4.75
Pattern of neutral polymorphism in a geographically structured population. Genet Res (1971) 4.65
On the constancy of the evolutionary rate of cistrons. J Mol Evol (1971) 4.49
Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg (1984) 4.45
The age of a neutral mutant persisting in a finite population. Genetics (1973) 4.44
Genetic variability and effective population size when local extinction and recolonization of subpopulations are frequent. Proc Natl Acad Sci U S A (1980) 4.37
The basal ganglia and adaptive motor control. Science (1994) 4.27
Interaction of colicins with bacterial cells. I. Studies with radioactive colicins. J Bacteriol (1966) 4.25
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol (2011) 4.22
Molecular evidence for the early evolution of photosynthesis. Science (2000) 4.17
Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension (2001) 4.07
Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature (1977) 4.00
Development of a pertussis component vaccine in Japan. Lancet (1984) 3.94
Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology (1999) 3.83
Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA. Nat Med (2001) 3.81
Distribution of allelic frequencies in a finite population under stepwise production of neutral alleles. Proc Natl Acad Sci U S A (1975) 3.64
Linkage disequilibrium between two segregating nucleotide sites under the steady flux of mutations in a finite population. Genetics (1971) 3.51
The average number of generations until extinction of an individual mutant gene in a finite population. Genetics (1969) 3.49
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology (2000) 3.42
Effect of overall phenotypic selection on genetic change at individual loci. Proc Natl Acad Sci U S A (1978) 3.41
Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension (2000) 3.32
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A (2001) 3.32
Stepwise mutation model and distribution of allelic frequencies in a finite population. Proc Natl Acad Sci U S A (1978) 3.29
Colorectal tumours and pit pattern. J Clin Pathol (1994) 3.01
Control of doublesex alternative splicing by transformer and transformer-2 in Drosophila. Science (1991) 2.87
Myeloscopy, with special reference to blood flow changes in the cauda equina during Lasègue's test. Int Orthop (1981) 2.82
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet (1998) 2.80
Mutation and evolution at the molecular level. Genetics (1973) 2.79
Experimental investigation of geologically produced antineutrinos with KamLAND. Nature (2005) 2.75
Growth site localization of Rho1 small GTP-binding protein and its involvement in bud formation in Saccharomyces cerevisiae. J Cell Biol (1994) 2.74
Requirement of CD9 on the egg plasma membrane for fertilization. Science (2000) 2.65
Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc Natl Acad Sci U S A (1985) 2.65
Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes. EMBO J (1999) 2.63
Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res (1999) 2.61
Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J Clin Microbiol (1990) 2.60
Tumor angiogenesis in human lung adenocarcinoma. Cancer (1994) 2.59
Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem (1983) 2.58
Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci (2001) 2.54
Fixation of a deleterious allele at one of two "duplicate" loci by mutation pressure and random drift. Proc Natl Acad Sci U S A (1979) 2.51
No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg (1999) 2.47
Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol (1999) 2.46
Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem (1999) 2.44
Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol (2001) 2.43
Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule. Clin Cancer Res (1999) 2.39
Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol (2000) 2.36
Glutamic acid 204 is the terminal proton release group at the extracellular surface of bacteriorhodopsin. J Biol Chem (1995) 2.36
Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer (1994) 2.34
Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res (1999) 2.28
Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun (1986) 2.27
Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res (1999) 2.26
Possibility of extensive neutral evolution under stabilizing selection with special reference to nonrandom usage of synonymous codons. Proc Natl Acad Sci U S A (1981) 2.23
Downregulation of caffeic acid 3-O-methyltransferase and caffeoyl CoA 3-O-methyltransferase in transgenic alfalfa. impacts on lignin structure and implications for the biosynthesis of G and S lignin. Plant Cell (2001) 2.23
Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase [corrected]. Nature (1994) 2.22
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J Biol Chem (2000) 2.18
Histochemistry of the surface mucous gel layer of the human colon. Gut (1997) 2.17
Molecular clock of viral evolution, and the neutral theory. Proc Natl Acad Sci U S A (1990) 2.15
Responses of tonically active neurons in the primate's striatum undergo systematic changes during behavioral sensorimotor conditioning. J Neurosci (1994) 2.14
Molecular cloning and nucleotide sequence of the cDNA for rat peroxisomal enoyl-CoA: hydratase-3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme. J Biol Chem (1985) 2.12
Sequence variation in the 18S rRNA gene, a target for PCR-based malaria diagnosis, in Plasmodium ovale from southern Vietnam. J Clin Microbiol (1996) 2.12
Structural analysis of the dnaA and dnaN genes of Escherichia coli. Gene (1984) 2.11
Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos (1996) 2.11
Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci U S A (1997) 2.10
Phage-conversion of toxigenicity in Clostridium botulinum types C and D. Jpn J Med Sci Biol (1971) 2.09
Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun (1990) 2.06
The length of time required for a selectively neutral mutant to reach fixation through random frequency drift in a finite population. Genet Res (1970) 2.05
A gene-counting method of maximum likelihood for estimating gene frequencies in ABO and ABO-like systems. Ann Hum Genet (1968) 2.05
Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant. Infect Immun (1985) 2.04
Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet (1995) 2.03
Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett (1986) 2.03
The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int (2006) 2.02
Lysenin, a novel sphingomyelin-specific binding protein. J Biol Chem (1998) 2.02
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis (2007) 2.01